Relay Therapeutics, Inc. (RLAY)
17.88
+0.47
(+2.70%)
USD |
NASDAQ |
Oct 09, 16:00
17.88
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Free Cash Flow : -212.20M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -212.20M |
| March 31, 2026 | -213.38M |
| December 31, 2025 | -235.86M |
| September 30, 2025 | -248.87M |
| June 30, 2025 | -262.06M |
| March 31, 2025 | -272.62M |
| December 31, 2024 | -251.12M |
| September 30, 2024 | -282.56M |
| June 30, 2024 | -283.24M |
| March 31, 2024 | -287.50M |
| December 31, 2023 | -304.44M |
| September 30, 2023 | -274.53M |
| June 30, 2023 | -266.78M |
| March 31, 2023 | -255.63M |
| Date | Value |
|---|---|
| December 31, 2022 | -238.55M |
| September 30, 2022 | -219.74M |
| June 30, 2022 | -206.44M |
| March 31, 2022 | -176.01M |
| December 31, 2021 | -77.88M |
| September 30, 2021 | -72.63M |
| June 30, 2021 | -42.16M |
| March 31, 2021 | -34.90M |
| December 31, 2020 | -104.42M |
| September 30, 2020 | -92.44M |
| June 30, 2020 | -87.86M |
| March 31, 2020 | -83.53M |
| December 31, 2019 | -74.14M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| SELLAS Life Sciences Group, Inc. | -28.42M |
| TG Therapeutics, Inc. | 17.38M |
| Karyopharm Therapeutics, Inc. | -65.35M |
| Spyre Therapeutics, Inc. | -209.47M |
| Akebia Therapeutics, Inc. | 40.26M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -54.11M |
| Cash from Investing (Quarterly) | -353.03M |
| Cash from Financing (Quarterly) | 323.74M |
| Free Cash Flow Per Share (Quarterly) | -0.2667 |
| Free Cash Flow to Equity (Quarterly) | -53.20M |
| Free Cash Flow to Firm (Quarterly) | -54.11M |
| Free Cash Flow Yield | -6.52% |